Shuttle Pharmaceuticals Holdings, Inc. Contracts & Agreements
86 Contracts & Agreements
- Business Finance (45 contracts)
- Business Operations (5)
- Human Resources (11)
- Intellectual Property (1)
- Uncategorized (24)
- Form of Promissory Note, dated September 4, 2024, between Shuttle Pharmaceuticals and Anatoly Dritschilo (Filed With SEC on September 10, 2024)
- Master Services Agreement, dated November 1, 2018, between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc (Filed With SEC on August 14, 2024)
- Work Order, dated August 8, 2024, between Shuttle Pharmaceuticals, Inc. and Theradex Systems, Inc (Filed With SEC on August 14, 2024)
- Amendment Agreement, dated August 6, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC Segregated Master... (Filed With SEC on August 7, 2024)
- Employment Agreement, dated June 13, 2024, between Shuttle Pharmaceuticals Holdings, Inc. and Timothy J. Lorber (Filed With SEC on June 18, 2024)
- Offering Deposit Account Agency Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Boustead Securities, LLC and Sutter Securities Inc (Filed With SEC on February 13, 2024)
- Placement Agent and Advisory Services Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc. and Boustead Securities, LLC (Filed With SEC on February 13, 2024)
- Securities Purchase Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Diagnostics, Inc. and SRO LLC (Filed With SEC on February 13, 2024)
- Asset Purchase Agreement, dated January 30, 2024, by and between Shuttle Pharmaceuticals Holdings, Inc., Alan Kozikowksi and Werner Tueckmantel (Filed With SEC on February 5, 2024)
- License Agreement, dated October 24, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc. and Georgetown University (Filed With SEC on October 30, 2023)
- Consulting Agreement, dated October 1, 2023, between Shuttle Pharmaceuticals Holdings, Inc. and Joseph Armstrong (Filed With SEC on October 5, 2023)
- Amendment No. 1 to the Amendment Agreement, dated June 4, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master... (Filed With SEC on June 5, 2023)
- Amendment Agreement, dated May 10, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC Segregated... (Filed With SEC on May 11, 2023)
- Material Transfer Agreement, dated March 21, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University (Filed With SEC on March 22, 2023)
- Research Agreement, dated March 16, 2023, between Shuttle Pharmaceuticals, Inc. and Georgetown University (Filed With SEC on March 22, 2023)
- Letter Agreement, dated March 11, 2023, between Shuttle Pharmaceuticals Holdings, Inc. and Alto Opportunity Master Fund, SPC Segregated Portfolio B, as Collateral Agent (Filed With SEC on March 15, 2023)
- Form of Executive Compensation Clawback Policy, effective March 10, 2023 (Filed With SEC on March 15, 2023)
- Amended and Restated Insider Trading Policy, effective March 10, 2023 (Filed With SEC on March 15, 2023)
- Proposal for Service Agreement, dated March 7, 2023, between Shuttle Pharmaceuticals, Inc. and University of Iowa Pharmaceuticals (Filed With SEC on March 9, 2023)
- Form of Director Letter Agreement (Filed With SEC on February 22, 2023)
- Form of Registration Rights Agreement (Filed With SEC on January 12, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on January 12, 2023)
- Form of Note (Filed With SEC on January 12, 2023)
- Form of Warrant (Filed With SEC on January 12, 2023)
- Form of Intellectual Property Security Agreement (Filed With SEC on January 12, 2023)
- Form of Subsidiary Guaranty (Filed With SEC on January 12, 2023)
- Form of Security Agreement (Filed With SEC on January 12, 2023)
- Form of Director Offer Letter (Filed With SEC on November 1, 2022)
- Manufacturing Agreement, dated September 14, 2022, between Shuttle Pharmaceuticals, Inc. and TCG GreenChem, Inc (Filed With SEC on September 19, 2022)
- Form of Public Offering Warrant (Filed With SEC on August 25, 2022)
- Form of Underwriting Agreement (Filed With SEC on August 25, 2022)
- Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 25, 2022)
- Form of Warrant, dated August 2022 (Filed With SEC on August 25, 2022)
- Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 25, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 25, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 25, 2022)
- Form of Underwriting Agreement (Filed With SEC on August 24, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 24, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 24, 2022)
- Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 24, 2022)
- Form of Public Offering Warrant (Filed With SEC on August 24, 2022)
- Form of Warrant, dated August 2022 (Filed With SEC on August 24, 2022)
- Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 24, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, inc. and Anatoly Dritschilo (Filed With SEC on August 19, 2022)
- Amendment No. 2 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals holdings, Inc. and Joy Dritschilo (Filed With SEC on August 19, 2022)
- Amendment No. 1 to Promissory Note, dated July 29, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on August 19, 2022)
- Form of Public Offering Warrant (Filed With SEC on August 19, 2022)
- Form of Warrant, dated August 2022 (Filed With SEC on August 19, 2022)
- Form of 10% Promissory Note, dated August 2022 (Filed With SEC on August 19, 2022)
- Form of Underwriting Agreement (Filed With SEC on August 19, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2022)
- Employment Agreement, dated July 30, 2014, between Shuttle Pharmaceuticals Holdings, Inc. and Tyvin Rich (Filed With SEC on June 23, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 23, 2022)
- Form of Underwriting Warrant issuable to Boustead Securities LLC (Filed With SEC on June 23, 2022)
- Subaward Agreement dated October 28, 2014 between Shuttle Pharmaceuticals, LLC and LifeSpan/Rhode Island Hospital (Filed With SEC on June 3, 2022)
- Form of Subscription Agreement for Series A Convertible Preferred Stock (Filed With SEC on June 3, 2022)
- Form of Letter Agreement with Director (Filed With SEC on June 3, 2022)
- Amended and Restated Employment Agreement, dated September 1, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Michael Vander Hoek (Filed With SEC on June 3, 2022)
- Employment Agreement, dated June 28, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly. Dritschilo (Filed With SEC on June 3, 2022)
- Employment Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Mira Jung (Filed With SEC on June 3, 2022)
- Employment Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Peter Dritschilo (Filed With SEC on June 3, 2022)
- Material Transfer Agreement, dated April 25, 2017, between Shuttle Pharmaceuticals, Inc. and George Washington University (Filed With SEC on June 3, 2022)
- SBIR Contract #HHSN261600038C dated September 19, 2016 between Shuttle Pharmaceuticals, LLC. and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)
- SBIR Contract #HHSN261201600027C, dated September 19, 2016, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)
- SBIR Contract #HHSN261201400013C Amendment of Solicitation/Modification of Contract, dated August 3, 2015, between Shuttle Pharmaceuticals, LLC and National Institute of Health... (Filed With SEC on June 3, 2022)
- SBIR Contract #HHSN261201400013C, dated September 19, 2014, between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)
- Employment Agreement, dated July 30, 2014, between Shuttle Pharmaceuticals Holdings, Inc. and Tyvin Rich (Filed With SEC on June 3, 2022)
- Code of Business Conduct and Ethics (Filed With SEC on June 3, 2022)
- 2018 Equity Incentive Plan (Filed With SEC on June 3, 2022)
- Form of Convertible Note, dated February 2022 (Filed With SEC on June 3, 2022)
- Sublicense Agreement, dated February 15, 2019, between Shuttle Pharmaceuticals Inc. and Propagenix, Inc (Filed With SEC on June 3, 2022)
- SBIR Contract #HHSN261201800016C/75N91018C00016 Agreement between Shuttle Pharmaceuticals, LLC and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)
- Promissory Note, dated as of August 24, 2019, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)
- SBIR Phase II Contract #75N9101C00031, dated September 6, 2019, between Shuttle Pharmaceuticals, Inc. and National Institute of Health National Cancer Institute (Filed With SEC on June 3, 2022)
- Director Offer Letter, dated December 2, 2020, between Chris Senanayake and Shuttle Pharmaceuticals Holdings, Inc (Filed With SEC on June 3, 2022)
- Promissory Note, dated December 1, 2020, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on June 3, 2022)
- Promissory Note, dated December 1, 2020, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)
- Non-Disclosure, Evaluation and Option Agreement, dated May 30, 2019, between Shuttle Pharmaceuticals, Inc. and University of Virginia Licensing & Ventures Group (Filed With SEC on June 3, 2022)
- First Amendment to Non-Disclosure, Evaluation and Option Agreement, dated November 30, 2019, between Shuttle Pharmaceutical, Inc. and University of Virginia Licensing & Ventures... (Filed With SEC on June 3, 2022)
- Form of Note and Warrant Subscription Agreement, dated December 28, 2021 (Filed With SEC on June 3, 2022)
- Form of Note, dated December 28, 2021 (Filed With SEC on June 3, 2022)
- Form of Common Stock Purchase Warrant, dated December 28, 2021 (Filed With SEC on June 3, 2022)
- Consulting Agreement, dated January 1, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Steven Bayern (Filed With SEC on June 3, 2022)
- Amendment to Promissory Note, dated January 25, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Joy Dritschilo (Filed With SEC on June 3, 2022)
- Amendment to Promissory Note, dated January 25, 2022, between Shuttle Pharmaceuticals Holdings, Inc. and Anatoly Dritschilo (Filed With SEC on June 3, 2022)
- Form of Convertible Note Subscription Agreement and Investor Rights Agreement (Filed With SEC on June 3, 2022)